In additional experiments, Chen et al. [42] later showed that KMP decreased the DNA-binding activity of activator protein-1 transcription factor (AP-1), suggesting a potential role of the compound in the treatment of osteosarcoma metastasis. Here, JUN is linked to osteosarcoma.